Concerning the KKS, an endocrine system that counterbalances RAS, a decrease in the kallikrein released into the urine of hypertensive patients with primary aldosteronism has been previously reported [52], but in hypertensive rat models, a decrease in the expression of this enzyme has been observed [53, 54]. Here, KLK4 is linked to primary aldosteronism.